Search research articles
Contact Us
Filters
Showing results (21-30 of 68) with videos related to
Page
of 7
Sort By:
Oncotarget
|
February 25, 2016
Soluble Tie2 overrides the heightened invasion induced by anti-angiogenesis therapies in gliomas
Nahir Cortes-Santiago, Mohammad B Hossain, Konrad Gabrusiewicz, et al.
Journal of Proteome Research
|
July 18, 2015
Integrated Transcriptomic and Glycomic Profiling of Glioma Stem Cell Xenografts
Norelle C Wildburger, Shiyue Zhou, Lauren G Zacharias, et al.
Journal of Neurosurgery
|
September 7, 2019
Microcatheter delivery of neurotherapeutics: compatibility with mesenchymal stem cells
Visish M Srinivasan, Joy Gumin, Kevin M Camstra, et al.
Molecular Cancer Therapeutics
|
February 1, 2017
Preclinical Evaluation of Sequential Combination of Oncolytic Adenovirus Delta-24-RGD and Phosphatidylserine-Targeting Antibody in Pancreatic Ductal Adenocarcinoma
Bingbing Dai, David Roife, Ya'an Kang, et al.
Neuro-Oncology
|
October 11, 2017
Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas
Frederick M Lang, Anwar Hossain, Joy Gumin, et al.
Journal of Neuro-Oncology
|
March 1, 2005
PAX6 suppresses growth of human glioblastoma cells
Yi-Hong Zhou, Xiaosong Wu, Fang Tan, et al.
Journal of Neurosurgery
|
August 27, 2021
Characterization of patient-derived bone marrow human mesenchymal stem cells as oncolytic virus carriers for the treatment of glioblastoma
Yuzaburo Shimizu, Joy Gumin, Feng Gao, et al.
Neuro-Oncology Advances
|
November 26, 2020
RNAi technology targeting the <i>FGFR3-TACC3</i> fusion breakpoint: an opportunity for precision medicine
Brittany C Parker Kerrigan, Daniel Ledbetter, Matthew Kronowitz, et al.
Neuro-Oncology Advances
|
October 15, 2019
GITRL-armed Delta-24-RGD oncolytic adenovirus prolongs survival and induces anti-glioma immune memory
Yisel Rivera-Molina, Hong Jiang, Juan Fueyo, et al.
Molecular Cancer Therapeutics
|
January 8, 2010
Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway
Jun Wei, Jason Barr, Ling-Yuan Kong, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 68) with videos related to
Sort By:
Page
of 7
Oncotarget
|
February 25, 2016
Soluble Tie2 overrides the heightened invasion induced by anti-angiogenesis therapies in gliomas
Nahir Cortes-Santiago, Mohammad B Hossain, Konrad Gabrusiewicz, et al.
Journal of Proteome Research
|
July 18, 2015
Integrated Transcriptomic and Glycomic Profiling of Glioma Stem Cell Xenografts
Norelle C Wildburger, Shiyue Zhou, Lauren G Zacharias, et al.
Journal of Neurosurgery
|
September 7, 2019
Microcatheter delivery of neurotherapeutics: compatibility with mesenchymal stem cells
Visish M Srinivasan, Joy Gumin, Kevin M Camstra, et al.
Molecular Cancer Therapeutics
|
February 1, 2017
Preclinical Evaluation of Sequential Combination of Oncolytic Adenovirus Delta-24-RGD and Phosphatidylserine-Targeting Antibody in Pancreatic Ductal Adenocarcinoma
Bingbing Dai, David Roife, Ya'an Kang, et al.
Neuro-Oncology
|
October 11, 2017
Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas
Frederick M Lang, Anwar Hossain, Joy Gumin, et al.
Journal of Neuro-Oncology
|
March 1, 2005
PAX6 suppresses growth of human glioblastoma cells
Yi-Hong Zhou, Xiaosong Wu, Fang Tan, et al.
Journal of Neurosurgery
|
August 27, 2021
Characterization of patient-derived bone marrow human mesenchymal stem cells as oncolytic virus carriers for the treatment of glioblastoma
Yuzaburo Shimizu, Joy Gumin, Feng Gao, et al.
Neuro-Oncology Advances
|
November 26, 2020
RNAi technology targeting the <i>FGFR3-TACC3</i> fusion breakpoint: an opportunity for precision medicine
Brittany C Parker Kerrigan, Daniel Ledbetter, Matthew Kronowitz, et al.
Neuro-Oncology Advances
|
October 15, 2019
GITRL-armed Delta-24-RGD oncolytic adenovirus prolongs survival and induces anti-glioma immune memory
Yisel Rivera-Molina, Hong Jiang, Juan Fueyo, et al.
Molecular Cancer Therapeutics
|
January 8, 2010
Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway
Jun Wei, Jason Barr, Ling-Yuan Kong, et al.
Page
of 7